NARRATIVE: Durnell v. Monsanto — The Supreme Court Protects Bayer and Erases Thousands of Victims

NARRATIVE: Durnell v. Monsanto — The Supreme Court Protects Bayer and Erases Thousands of Victims

Introduction: June 25, a St. Louis gardener and Bayer's biggest legal victory in years

John Durnell, a St. Louis gardener, against a chemical empire

On June 25, 2026, the United States Supreme Court handed down its decision in Monsanto v. Durnell: seven votes to two to overturn the $1.25 million verdict a jury had awarded to John Durnell, a gardener from St. Louis, Missouri, diagnosed with non-Hodgkin's lymphoma he attributed to decades of exposure to Roundup. Justice Brett Kavanaugh wrote the majority opinion. Justice Ketanji Brown Jackson led the dissent. In a single ruling, the Court not only overturned Durnell's victory — it potentially shut the door on tens of thousands of similar pending lawsuits in American courts.

This decision is a historic win for Bayer, which acquired Monsanto in 2018 and inherited with it a colossal legal liability: thousands of plaintiffs claiming that glyphosate, Roundup's active ingredient, caused their cancer. For years, Bayer had been seeking a definitive legal exit from this quagmire. The Supreme Court just gave it one — at the expense of John Durnell and everyone like him.

The legal argument that changed everything: FIFRA federal preemption

The majority's central argument rests on the doctrine of federal preemption. Justice Kavanaugh wrote that Durnell's claim — grounded in state law and alleging that Monsanto had failed its duty to warn consumers of glyphosate's dangers — would impose on Roundup's labeling a requirement "in addition to or different from" the label required by the federal Environmental Protection Agency (EPA). And because the federal law FIFRA — the Federal Insecticide, Fungicide, and Rodenticide Act — expressly preempts state-law claims in this context, Durnell's lawsuit is barred. The EPA decided that no cancer warning was necessary — and that federal decision closes the door to state courts.

The logic is technically coherent within the framework of American federal law. It is politically devastating for the thousands of victims who had won verdicts or were awaiting their day before a jury. If the federal government says "no cancer warning on the label," no one can sue the company for omitting that warning — even though the WHO has classified glyphosate as "probably carcinogenic to humans" since 2015.

Glyphosate and the science: a debate the EPA resolved without consensus

The WHO, the EPA, and the scientific divide

In 2015, the International Agency for Research on Cancer (IARC) of the WHO classified glyphosate as Group 2A: "probably carcinogenic to humans." This classification was based on evidence of carcinogenicity in laboratory animals and limited evidence in humans. The association most often cited in epidemiological studies is with non-Hodgkin's lymphoma — exactly the cancer diagnosed in John Durnell after decades of using Roundup in his gardening work.

The EPA, for its part, evaluated glyphosate and concluded in February 2020 that it is "not likely" to cause cancer in humans and that there are "no risks of concern to human health when glyphosate is used in accordance with its current label." But that conclusion itself was challenged in court — and the EPA ultimately withdrew those specific claims, leaving the product's safety "under formal review" at the very moment the Supreme Court was deciding the Durnell litigation. The science regulating the product is uncertain. The Court has ruled anyway.

Tens of thousands of lawsuits: what the decision erases

The potential scope of the Monsanto v. Durnell decision goes far beyond John Durnell's individual case. Legal experts cite the possibility that it affects "tens of thousands of pending lawsuits" in state and federal courts against Bayer. This litigation represents one of the largest mass tort actions in American history over a chemical product. Farmers, gardeners, grounds maintenance workers — all had used Roundup, many had developed non-Hodgkin's lymphoma, and many had initiated legal proceedings.

With the Supreme Court ruling, the dominant legal theory in those suits — failure-to-warn liability under state law — is now preempted by federal law. Durnell's attorney, Ashley Keller, argued that state juries should still be able to evaluate these cases "until Congress acts." The Court's majority said no.

The history of Bayer and the 2018 Monsanto acquisition

A toxic legacy at $63 billion

Bayer AG, the German pharmaceutical and agrochemical giant, acquired Monsanto in 2018 for approximately $63 billion — one of the decade's largest industrial mergers. With this acquisition, Bayer became the world's leading seed and herbicide manufacturer. But it also inherited a legal liability its own analysts had underestimated: thousands of Roundup lawsuits already pending or announced in the United States.

Since 2018, Bayer settled some of these cases for billions of dollars, but the lawsuits kept coming. CEO Bill Anderson stated after the Supreme Court ruling that the litigation had carried "enormous costs" for the company and had "damaged public trust" in the product. The decision, he said, delivers "long-overdue justice" and provides the "regulatory clarity needed for innovators like us to develop the agricultural tools that ensure an affordable food supply."

Make America Healthy Again against Trump

The political dimension of this case is strikingly ironic. The Trump administration sided with Bayer in this litigation — reversing the Biden administration's position, which had supported the plaintiffs. But this support for Monsanto/Bayer has created a fracture within the MAHA movement — Make America Healthy Again — whose activists had broadly supported Trump's political rise on the basis of promises of transparency on agricultural and food chemicals.

The contradiction is stark: Trump not only supported Bayer in this case, he also signed an executive order to boost domestic glyphosate production. For MAHA activists who believed their candidate — or their movement — would carry a revolution in agricultural regulation, this is a brutal repudiation. The agrochemical industry's interests prevailed over electoral health promises.

The Jackson dissent: a victim without recourse

The justice who protects individuals against corporations

Justice Ketanji Brown Jackson wrote a dissent that goes straight to the human problem the majority buries in its technical preemption reasoning. She writes that the decision "leaves Durnell without a remedy for the significant harm he suffered." This is not rhetorical flourish — it is a precise description of the situation: a man with blood cancer, who used Roundup for decades, who won his case before a popular jury, and who now has no compensation because a federal agency had decided under industry pressure that the product's label needed no cancer warning.

On the legal merits, Jackson argues that the majority "misunderstood the requirements of FIFRA" and "misinterpreted the scope of FIFRA preemption." According to her, adding a cancer warning to the Roundup label would not conflict with federal law — because federal law sets minimums, not maximums. States could require additional warnings without violating FIFRA. The majority, according to Jackson, chose a more restrictive interpretation that maximizes corporate protection.

The Paul Clement argument: uniformity against local justice

Paul Clement, the attorney for Monsanto/Bayer, had argued before the Court that there should be "a single uniform standard" for pesticide labeling, and that FIFRA places the EPA in charge. Fifty states with fifty different standards for pesticide warnings would create regulatory confusion and unfair burdens on manufacturers operating nationally. This is a practical argument about industrial management.

But it comes at a cost: the cost borne by victims living and dying in states that wanted to protect their citizens differently. The doctrine of federal uniformity is not neutral — it transfers the power to protect individuals from local juries (who see victims in the flesh) to federal agencies (who see data and lobbyists). This power transfer has winners — large corporations whose products are under scrutiny — and losers — individuals like John Durnell.

Roundup, glyphosate, and forty years of global agriculture

The planet's most widely used herbicide

Roundup was created by Monsanto in the 1970s. Over decades of expansion, it became the world's most widely used herbicide. Its active ingredient glyphosate is sprayed across billions of hectares annually — in corn, soy, cotton, and wheat fields; in parks, sidewalks, and private gardens; by railways to maintain their tracks; by municipal services to maintain green spaces. Its environmental presence is now ubiquitous: it is detected in the urine of people who never garden, in rainwater, in processed foods.

This ubiquity is precisely what makes the scientific debate over its carcinogenicity so crucial. If glyphosate even marginally contributes to the development of non-Hodgkin's lymphoma, its exposure level in the general population represents a considerable public health issue. The current scientific uncertainty — the WHO says probably carcinogenic, the EPA says unlikely, and the EPA itself withdrew its most confident claims under legal challenge — should not be resolved by a company's legal victory. It should be resolved by science.

Bayer confronting Monsanto's history

Monsanto carries a difficult history with controversial products: Agent Orange, the defoliant used during the Vietnam War; PCBs, polychlorinated biphenyls; dioxin; and now glyphosate. In each of these cases, decades passed between the first scientific alerts, corporate denials, and final judicial or regulatory condemnations. Bayer acquired Monsanto knowing — or needing to know — that the glyphosate file was open. The Supreme Court ruling closes that litigation file, at least for warning-defect liability theories.

But it does not close the scientific debate. The EPA continues its formal review of glyphosate. Epidemiological studies continue to be published. European countries have restricted or banned its use. France progressively reduced its usage. The European Union periodically renews its license amid intense controversy. The American judicial ruling of June 25, 2026 does not say Roundup is safe — it says Bayer cannot be sued for failing to warn that perhaps it isn't.

What remains for the victims: Congress as the last hope

Ashley Keller and the legislative path

Durnell's attorney, Ashley Keller, refused to accept that the Court's decision was the end of the story. He argued that state juries should still be able to evaluate these cases "until Congress acts." This formulation implicitly acknowledges that the judicial route is exhausted — that the last hope for Roundup victims is federal legislative action that would explicitly amend FIFRA to allow state claims over chemical product warnings.

The chances of such legislation in the current American political climate are slim. Congress is dominated by Republicans who sided with the corporation in this litigation. The Trump administration signed an executive order to produce more glyphosate. Agrochemical industry lobbyists exercise considerable influence over agricultural policy. Individual victims like John Durnell do not have the resources of the Farm Bureau or CropLife America to shape legislation.

The European path: a regulatory alternative

While American justice closes its doors to American Roundup victims, Europe offers a striking contrast. The European Union has repeatedly and intensely debated renewing glyphosate's license — the most recent controversial extension runs through 2033. Several member states — including France, which had promised a phase-out — have adopted usage restrictions that do not depend on the decisions of a single federal agency but on complex evaluation processes involving the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA).

This European model has its own problems — license renewals are often the product of political compromise as much as scientific assessment. But it preserves the possibility of differentiated national regulation, and does not preempt civil claims from victims in the same way that American FIFRA does. European Roundup victims retain more recourse than their American counterparts after the Supreme Court decision.

The MAHA movement and the fracture with the Trump administration

A movement betrayed by its own allies

The Make America Healthy Again (MAHA) movement, associated with Robert F. Kennedy Jr. and his allies, had made transparency on agricultural and food chemicals a central issue. MAHA activists had mobilized outside the Supreme Court during the Durnell hearings, supporting the Roundup victims. Some had voted for or supported Trump precisely based on implicit or explicit promises to break with conventional chemical agriculture and protect Americans' health.

Trump's executive order to boost domestic glyphosate production, combined with his administration's support of Bayer in the Durnell litigation, sends an unambiguous signal: the agrochemical industry's interests take priority over the MAHA agenda. This fracture is not marginal — it strikes at one of the fundamental reasons why an atypical coalition of voters had supported Trump in his last campaign. The promises of disrupting the food and chemical establishment collided with the reality of industrial pressures and the agricultural sector's economic interests.

Public health as a complex political issue

The Monsanto v. Durnell decision illustrates the deeply political nature of chemical product regulation in America. The EPA's decisions on pesticide safety are not made in a scientific vacuum — they are influenced by interest group resources, the composition of successive administrations, budget priorities, and political will to resist industrial pressure. When these decisions become the legal standard preempting all civil liability, the balance between corporate protection and individual protection shifts radically.

This shift is the legacy of Wolford v. Lopez and Monsanto v. Durnell together — two decisions handed down the same day, June 25, 2026, that illustrate the trajectory of a conservative Supreme Court: protect individual rights when they align with the majority's ideological preferences (the Second Amendment), and protect corporations when individual claims threaten regulatory predictability.

Prior Bayer convictions and the hope of settlements

The three early verdicts that gave hope

Before the Supreme Court ruled, three American court decisions had given Roundup victims hope. In 2018, Dewayne Johnson, a school groundskeeper with non-Hodgkin's lymphoma, won a verdict of $289 million — reduced on appeal but upheld in principle. In 2019, Edwin Hardeman and Alva and Alberta Pilliod also won significant verdicts. These successive decisions forced Bayer into large-scale settlement negotiations — in 2020, the company announced a settlement of $10.9 billion to resolve most pending cases.

But that settlement did not close all cases. New plaintiffs kept coming. The Durnell case was one of those that refused the settlement and persisted all the way to the Supreme Court. The June 25, 2026 ruling fundamentally shifts the balance of power in future negotiations: without the threat of a possible jury verdict, the pressure on Bayer to offer reasonable settlements evaporates. The thousands of remaining plaintiffs now negotiate without cards to play.

The science that continues regardless

The Supreme Court's decision does not close the scientific debate on glyphosate. Epidemiological studies continue to be published. The Pesticide Action Network and various public health organizations maintain pressure for an international reassessment of the product. The American EPA is still officially "reviewing" glyphosate safety after withdrawing its 2020 claims under legal challenge. Countries like France and Austria maintain usage restrictions that American farmers do not have.

Science, unlike law, does not yield to Supreme Court rulings. If future research establishes with greater certainty a causal link between glyphosate and non-Hodgkin's lymphoma, the Durnell decision will be remembered as a moment when the American legal system protected a corporation against emerging truth. This is not unprecedented in American chemical regulation history — tobacco, asbestos, and leaded gasoline all followed this path. History eventually caught up with those industries. It may catch up with glyphosate too.

Conclusion: John Durnell and the thousands like him

One man, one cancer, one verdict annulled

John Durnell used Roundup for decades in his gardening work in St. Louis. He developed non-Hodgkin's lymphoma. A Missouri state jury awarded him $1.25 million in 2023. The United States Supreme Court has now told him that verdict does not stand — not because his illness is not real, not because the link between glyphosate and his cancer is refuted by science, but because a federal agency had decided, under industry pressure, that no cancer warning was required on the label of the product he used.

Behind John Durnell, there are tens of thousands of people in the same situation — farmers, gardeners, grounds maintenance workers — who had filed legal proceedings and who today receive the same answer. The American system operated according to its own rules. Federal law overrides state law. The EPA has the final say on labeling. Bayer is protected. And John Durnell has no recourse.

What this decision says about the state of American law

On this June 25, 2026, the American Supreme Court handed down two major decisions: Wolford v. Lopez on guns, and Monsanto v. Durnell on Roundup. In both cases, the conservative majority expanded corporate and gun-related individual rights while restricting individual victims' recourse against corporations. This coherent ideological line is not accidental — it is the result of a judicial architecture built over decades of strategic Supreme Court nominations.

For the millions of Americans still using Roundup in their gardens and fields, who do not read Supreme Court decisions, who trust federal agencies to protect their health — this ruling is invisible. Until the day they receive their diagnosis. Then it may be too late to understand that the law already decided for them. In Bayer's favor.

By Maxime Marquette, columnist

Columnist's transparency note

Sources and method

This article is based on directly verifiable primary sources: the New York Times, NPR, and the Bayer website covering the June 25, 2026 decision. Quotes from Justice Kavanaugh, Justice Jackson, Bayer CEO Bill Anderson, and attorney Ashley Keller come directly from the NYT and NPR articles. The WHO's classification of glyphosate as "probably carcinogenic" is a documented fact since 2015. The annulled verdict amount ($1.25 million) and the details of the Durnell case are verified by multiple concordant sources.

Editorial positioning

This narrative takes a critical perspective on the majority decision, highlighting its impact on the rights of individual victims facing large corporations. The author considers the federal preemption doctrine, as applied in this case, to unbalance protection of individuals in favor of corporate interests. This position does not invalidate the legal coherence of the decision within the American legal framework — it questions it on the level of values and social priorities.

Sources

Primary sources

New York Times — US Supreme Court rejects lawsuit alleging Roundup weedkiller caused cancer — June 25, 2026

NPR — U.S. Supreme Court backs Monsanto in its fight against liability from Roundup — June 25, 2026

Bayer — Monsanto wins landmark Roundup case at US Supreme Court — June 25, 2026

Secondary sources

Chemical & Engineering News — Bayer/Monsanto glyphosate Supreme Court ruling — June 2026

Drugwatch — Roundup lawsuit history and legal developments

United States Supreme Court — Official opinion Monsanto v. Durnell — June 25, 2026